Literature DB >> 11705892

Effect of 6-hydroxydopamine on host resistance against Listeria monocytogenes infection.

T Miura1, T Kudo, A Matsuki, K Sekikawa, Y Tagawa, Y Iwakura, A Nakane.   

Abstract

Recent studies have shown that immunocompetent cells bear receptors of neuropeptides and neurotransmitters and that these ligands play roles in the immune response. In this study, the role of the sympathetic nervous system in host resistance against Listeria monocytogenes infection was investigated in mice pretreated with 6-hydroxydopamine (6-OHDA), which destroys sympathetic nerve termini. The norepinephrine contents of the plasma and spleens were significantly lower in 6-OHDA-treated mice than in vehicle-treated mice. The 50% lethal dose of L. monocytogenes was about 20 times higher for 6-OHDA-treated mice than for vehicle-treated mice. Chemical sympathectomy by 6-OHDA upregulated interleukin-12 (IL-12) and tumor necrosis factor-alpha (TNF-alpha) production in enriched dendritic cell cultures and gamma interferon (IFN-gamma) and TNF-alpha production in spleen cell cultures, whereas chemical sympathectomy had no apparent effect on phagocytic activities, listericidal activities, and nitric oxide production in peritoneal exudate cells and splenic macrophages. Augmentation of host resistance against L. monocytogenes infection by 6-OHDA was abrogated in IFN-gamma(-/-) or TNF-alpha(-/-) mice, suggesting that upregulation of IFN-gamma, IL-12, and TNF-alpha production may be involved in 6-OHDA-mediated augmentation of antilisterial resistance. Furthermore, adoptive transfer of spleen cells immune to L. monocytogenes from 6-OHDA-treated mice resulted in untreated naive recipients that had a high level of resistance against L. monocytogenes infection. These results suggest that the sympathetic nervous system may modulate host resistance against L. monocytogenes infection through regulation of production of IFN-gamma, IL-12, and TNF-alpha, which are critical in antilisterial resistance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705892      PMCID: PMC98806          DOI: 10.1128/IAI.69.12.7234-7241.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

1.  Noradrenergic and peptidergic innervation of secondary lymphoid organs: role in experimental rheumatoid arthritis.

Authors:  D L Felten; S Y Felten; D L Bellinger; D Lorton
Journal:  Eur J Clin Invest       Date:  1992-10       Impact factor: 4.686

2.  Sympathetic neural modulation of the immune system. I. Depression of T cell immunity in vivo and vitro following chemical sympathectomy.

Authors:  K S Madden; S Y Felten; D L Felten; P R Sundaresan; S Livnat
Journal:  Brain Behav Immun       Date:  1989-03       Impact factor: 7.217

3.  Administration of anti-IL-4 monoclonal antibody 11B11 increases the resistance of mice to Listeria monocytogenes infection.

Authors:  M Haak-Frendscho; J F Brown; Y Iizawa; R D Wagner; C J Czuprynski
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

4.  Sympathetic nervous system modulation of the immune system. II. Induction of lymphocyte proliferation and migration in vivo by chemical sympathectomy.

Authors:  K S Madden; S Y Felten; D L Felten; C A Hardy; S Livnat
Journal:  J Neuroimmunol       Date:  1994-01       Impact factor: 3.478

5.  Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes.

Authors:  J Rothe; W Lesslauer; H Lötscher; Y Lang; P Koebel; F Köntgen; A Althage; R Zinkernagel; M Steinmetz; H Bluethmann
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

6.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

7.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

8.  Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

Authors:  K Pfeffer; T Matsuyama; T M Kündig; A Wakeham; K Kishihara; A Shahinian; K Wiegmann; P S Ohashi; M Krönke; T W Mak
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

9.  Tumor necrosis factor modulates the inactivation of catecholamine secretion in cultured sympathetic neurons.

Authors:  B Soliven; J Albert
Journal:  J Neurochem       Date:  1992-03       Impact factor: 5.372

10.  An anti-CD3 monoclonal antibody protects mice against a lethal infection with Listeria monocytogenes through induction of endogenous cytokines.

Authors:  A Nakane; M Okamoto; M Asano; M Kohanawa; T Minagawa
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

View more
  7 in total

Review 1.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

2.  Neural control of the immune system.

Authors:  Eva Sundman; Peder S Olofsson
Journal:  Adv Physiol Educ       Date:  2014-06       Impact factor: 2.288

Review 3.  Spinal cord injury, immunodepression, and antigenic challenge.

Authors:  Katherine S Held; Thomas E Lane
Journal:  Semin Immunol       Date:  2014-04-18       Impact factor: 11.130

4.  Chemical sympathectomy increases susceptibility to ocular herpes simplex virus type 1 infection.

Authors:  Amanda Templeton; Gabrielle Nguyen; John D Ash; Rainer H Straub; Daniel J J Carr
Journal:  J Neuroimmunol       Date:  2008-05-20       Impact factor: 3.478

5.  Autonomic Regulation of Nociceptive and Immunologic Changes in a Mouse Model of Complex Regional Pain Syndrome.

Authors:  Peyman Sahbaie; Wen-Wu Li; Tian-Zhi Guo; Xiao-You Shi; Wade S Kingery; J David Clark
Journal:  J Pain       Date:  2021-10-23       Impact factor: 5.820

Review 6.  The dopaminergic system in autoimmune diseases.

Authors:  Rodrigo Pacheco; Francisco Contreras; Moncef Zouali
Journal:  Front Immunol       Date:  2014-03-21       Impact factor: 7.561

7.  The role of autonomic efferents and uncoupling protein 1 in the glucose-lowering effect of leptin therapy.

Authors:  Heather C Denroche; Michelle M Kwon; Maria M Glavas; Eva Tudurí; Marion Philippe; Whitney L Quong; Timothy J Kieffer
Journal:  Mol Metab       Date:  2016-06-24       Impact factor: 7.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.